In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer

Keyphrases

• Ovarian Cancer 100%
• Adenovirus 100%
• P53 Gene Therapy 100%
• Dosing Regimen 28%
• Nude Mice 28%
• Cancer Therapy 14%
• Tumor Cells 14%
• Adverse Effects 14%
• Increased Dose 14%
• Clinical Application 14%
• Treatment Response 14%
• Treatment Schedule 14%
• Biologically Active 14%
• One-group 14%
• Intraperitoneal Injection 14%
• Administration Regimen 14%
• Tumor Inhibition 14%
• Wild-type p53 14%
• TP53 mutation 14%
• Survival Time 14%
• Gene Therapy 14%
• Cancer Gene Therapy 14%
• Safety Efficacy 14%
• Survival Benefit 14%
• Nude Mouse Model 14%
• Human Ovarian Cancer Cell 14%
• Survival Duration 14%
• Safety Toxicity 14%

Medicine and Dentistry

• Adenoviridae 100%
• Gene Therapy 100%
• Ovarian Cancer 100%
• Protein P53 100%
• Galactose 16%
• Phenformin 16%
• Adverse Event 8%
• Treatment Response 8%
• Drug Dose Regimen 8%
• Intraperitoneal Drug Administration 8%
• Tumor Cell 8%
• Cancer Therapy 8%
• Survival Time 8%
• Cancer Gene Therapy 8%
• Ovarian Cancer Cell Line 8%
• Cancer Inhibition 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein P53 100%
• Ovary Cancer 100%
• Adenoviridae 100%
• Nude Mouse 25%
• Galactose 16%
• Phenformin 16%
• Adverse Event 8%
• Mouse Model 8%
• Malignant Neoplasm 8%
• Neoplasm 8%
• Intraperitoneal Injection 8%
• Cancer Inhibition 8%
• Survival Time 8%